A health tourism project slated to be developed in Montego Bay over the next five years is among the plans for enhanced collaboration between Jamaica and India being supported by new High Commissioner Runsung Masakui.
The tourism project, estimated to cost about $40 billion, will be done by a member of the Indian diaspora in Jamaica.
Boosting trade and investment flows, as well as technical collaboration between the two countries, is the main goal Masakui has set for his three-year tenure, which started in November last year. The emphasis, he says, will be on high-value, tertiary health services, including health tourism projects, pharmaceuticals and telemedicine; knowledge-based enterprises encompassing technical training and the buildout of broadband internet across Jamaica; and helping to ramp up agriculture-based food processing here for export to his country.
Already, the Indian mission has thrown its support behind the health tourism development being pioneered by the Montego Bay-based Bioprist Group, controlled by Dr Guna Muppuri, a businessman, real estate developer and medical doctor who holds Indian and Jamaican nationalities. Bioprist Group also owns pharmaceutical products developer and distributor Indies Pharma Jamaica Limited, as well as the Bioprist Knowledge Park business process outsourcing enterprise.
Leave A Comment